ADMA Biologics, Inc. (ADMA) News
Track canonical SquawkNews coverage tagged to ADMA, ADMA Biologics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 19 indexed stories across 12 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Ten healthcare stocks with A-rated valuations and strong revenue growth
Healthcare stocks remain a focal point for investors as pharmaceutical innovation, biotechnology advancements, and managed care expansion continue to drive growth across the sector.While many healthcare companies trade a
EQUITY | Sep 09, 2026, 03:01 PM UTC
L
ADMA Biologics Affirms FY2026 Sales Guidance of $530.000M-$560.000M vs $559.495M Est
ADMA Biologics (NASDAQ: ADMA ) affirms FY2026 sales outlook from $530.000 million-$560.000 million to $530.000 million-$560.000 million vs $559.495 million estimate.
EARNINGS | Aug 05, 2026, 08:24 PM UTC
L
ADMA - ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
ADMA - ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Aug 05, 2026, 08:05 PM UTC
H
ADMA Biologics Faces Securities Fraud Class Action
ADMA stock drops 29% on channel stuffing allegations
EQUITY | Aug 04, 2026, 10:36 AM UTC
L
ADMA Faces Securities Fraud Class Action
ADMA investors advised to inquire about securities fraud class action
EQUITY | Aug 03, 2026, 01:54 PM UTC
H
ADMA Biologics Sued
ADMA Biologics faces securities law violations lawsuit
EQUITY | Jul 31, 2026, 06:52 AM UTC
L
ADMA: Lawsuit Lead Plaintiff Deadline August 10
ADMA lawsuit lead plaintiff deadline nears
FX | Jul 30, 2026, 02:07 PM UTC
L
ADMA - ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
ADMA - ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
EARNINGS | Jul 29, 2026, 11:01 AM UTC
L
ADMA - ADMA Class Reminder: ADMA Biologics Investors are Reminded of the Upcoming August 10 Deadline in the Filed Securities Fraud Class Act
ADMA - ADMA Class Reminder: ADMA Biologics Investors are Reminded of the Upcoming August 10 Deadline in the Filed Securities Fraud Class Action to Recover Losses
EQUITY | Jul 28, 2026, 10:37 AM UTC
L
ADMA - ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed - Click
ADMA - ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed
EQUITY | Jul 27, 2026, 01:30 PM UTC
L
ADMA Investor Alert: ADMA Biologics Investors Notified of the Important August 10 Deadline in Filed Securities Fraud Class Action Lawsuit
A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating f
REGULATION | Jul 05, 2026, 11:11 AM UTC
L
$ADMA Stock Loss Notice: ADMA Biologics Investors That Lost Money When Stock Plummeted 29% May Have Rights in Securities Fraud Class Action
NEW YORK CITY, NY / / July 4, 2026 / Leading securities law firm
EQUITY | Jul 04, 2026, 10:19 AM UTC
L
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class
New York, New York--(. - July 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9
EQUITY | Jul 03, 2026, 09:18 PM UTC
L
Levi & Korsinsky Urges ADMA Biologics, Inc. (ADMA) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026
NEW YORK, NY / / July 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has b
EQUITY | Jul 03, 2026, 09:15 PM UTC
L
ADMA Court Reminder: ADMA Biologics Investors are Notified to Act before the Upcoming Securities Fraud Class Action Deadline on August 10
A securities fraud class action lawsuit has been filed on behalf of ADMA Biologics investors after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating f
EQUITY | Jul 03, 2026, 07:19 PM UTC
L
Levi & Korsinsky Notifies ADMA Biologics, Inc. (ADMA) Investors - Lead Plaintiff Deadline on August 10, 2026
NEW YORK CITY, NY / / July 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit
EQUITY | Jul 03, 2026, 12:35 PM UTC
L
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class A
NEW YORK CITY, NY / / July 3, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, re
EQUITY | Jul 03, 2026, 12:00 PM UTC
L
ADMA Biologics, Inc. (ADMA) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before August 10, 2026
NEW YORK CITY, NY / / July 3, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit
EQUITY | Jul 03, 2026, 04:15 AM UTC
L
Join Class Action to Recover Losses from ADMA Biologics, Inc. (ADMA) - Contact Levi & Korsinsky Before August 10, 2026
NEW YORK CITY, NY / / July 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit
EQUITY | Jul 03, 2026, 01:45 AM UTC